MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 84 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,520,017 | -25.9% | 1,431,058 | 0.0% | 1.29% | -19.6% |
| Q2 2023 | $15,541,290 | +157296.1% | 1,431,058 | 0.0% | 1.60% | +29.7% |
| Q1 2023 | $9,874 | +73.3% | 1,431,058 | 0.0% | 1.23% | +93.7% |
| Q4 2022 | $5,696 | -99.9% | 1,431,058 | 0.0% | 0.64% | -43.9% |
| Q3 2022 | $9,517,000 | +37.4% | 1,431,058 | 0.0% | 1.14% | +39.9% |
| Q2 2022 | $6,926,000 | -48.2% | 1,431,058 | 0.0% | 0.81% | -37.5% |
| Q1 2022 | $13,380,000 | -21.3% | 1,431,058 | 0.0% | 1.30% | -3.6% |
| Q4 2021 | $17,001,000 | +4.4% | 1,431,058 | 0.0% | 1.35% | +33.5% |
| Q3 2021 | $16,285,000 | -36.6% | 1,431,058 | 0.0% | 1.01% | -40.0% |
| Q2 2021 | $25,673,000 | +15.9% | 1,431,058 | 0.0% | 1.68% | +34.0% |
| Q1 2021 | $22,153,000 | – | 1,431,058 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |